Case Report
Reversal of Dabigatran Using Idarucizumab in a Septic Patient with Impaired Kidney Function in Real-Life Practice
Table 1
Coagulation tests.
| Parameter | Standard values | Before idarucizumab | 10 minutes after g idarucizumab | 24 hours after idarucizumab |
| INR | | 1.56 | 1.23 | 1.10 | aPTT (sec) | 25.0–36.0 | 61 | 30.2 | 41.5 | Thrombin time (sec) | 11.5–19.4 | >120 | 16.2 | 52.9 | Fibrinogen (g/L) | 1.75–3.75 | 7.11 | 7.11 | 7.09 | Dabigatran (ng/mL) | | 119.05 | <30.0 | <30.0 |
|
|
Activated partial thromboplastin time (aPTT); international normalised ratio (INR).
|